InsiderClue
Insiders · Profile

McNeill Jonathan

President and COO at CRESCENT BIOPHARMA · Chief Business Officer at Dyne Therapeutics. Filing since 20 Sep 2021. CIK 0001824673

CBIO CRESCENT BIOPHARMA, INC. President and COO · 3 trades DYN Dyne Therapeutics, Inc. Chief Business Officer · 25 trades
Company
Date
Role
Action
Shares
Amount
Of holding
CBIO CRESCENT BIOPHARMA, INC.
18 Sep 2026
President and COO
Sold on a plan
3,839
$64.15K
2.8%
CBIO CRESCENT BIOPHARMA, INC.
16 Sep 2026
President and COO
Sold on a plan
731
$13.08K
0.5%
CBIO CRESCENT BIOPHARMA, INC.
22 Jun 2026
President and COO
Sold on a plan
20,549
$369.68K
12.9%
DYN Dyne Therapeutics, Inc.
19 Aug 2024
Chief Business Officer
Sold on a plan
2,705
$122.05K
2.0%
DYN Dyne Therapeutics, Inc.
11 Jun 2024
Chief Business Officer
Sold at will
1,823
$57.13K
1.3%
DYN Dyne Therapeutics, Inc.
16 May 2024
Chief Business Officer
Sold on a plan
2,774
$78.42K
2.0%
DYN Dyne Therapeutics, Inc.
11 Mar 2024
Chief Business Officer
Sold on a plan
19,601
$499.84K
12.3%
DYN Dyne Therapeutics, Inc.
8 Mar 2024
Chief Business Officer
Sold on a plan
90,000
$2.36M
38.9%
DYN Dyne Therapeutics, Inc.
7 Mar 2024
Chief Business Officer
Sold on a plan
2,434
$62.92K
1.7%
DYN Dyne Therapeutics, Inc.
1 Mar 2024
Chief Business Officer
Sold on a plan
24,260
$694.50K
14.5%
DYN Dyne Therapeutics, Inc.
29 Feb 2024
Chief Business Officer
Sold on a plan
4,268
$117.37K
2.9%
DYN Dyne Therapeutics, Inc.
26 Jan 2024
Chief Business Officer
Sold on a plan
20,000
$490.51K
12.2%
DYN Dyne Therapeutics, Inc.
4 Jan 2024
Chief Business Officer
Sold on a plan
2,009
$36.24K
1.4%
DYN Dyne Therapeutics, Inc.
3 Jan 2024
Chief Business Officer
Sold on a plan
17,991
$337.06K
11.1%
DYN Dyne Therapeutics, Inc.
2 Jan 2024
Chief Business Officer
Sold on a plan
11,900
$155.89K
7.7%
DYN Dyne Therapeutics, Inc.
11 Dec 2023
Chief Business Officer
Sold at will
1,245
$13.35K
0.8%
DYN Dyne Therapeutics, Inc.
18 Sep 2023
Chief Business Officer
Sold at will
1,261
$11.87K
2.0%
DYN Dyne Therapeutics, Inc.
12 Sep 2023
Chief Business Officer
Sold on a plan
1,266
$13.18K
2.0%
DYN Dyne Therapeutics, Inc.
13 Jun 2023
See Remarks
Sold on a plan
1,259
$15.65K
2.0%
DYN Dyne Therapeutics, Inc.
12 Jun 2023
See Remarks
Sold on a plan
1,000
$13.00K
1.5%
DYN Dyne Therapeutics, Inc.
14 Mar 2023
See Remarks
Sold, plan not stated
1,209
$16.12K
1.8%
DYN Dyne Therapeutics, Inc.
13 Mar 2023
See Remarks
Sold, plan not stated
1,000
$13.00K
1.5%
DYN Dyne Therapeutics, Inc.
18 Jan 2023
See Remarks
Sold, plan not stated
10,000
$140.30K
12.9%
DYN Dyne Therapeutics, Inc.
9 Jan 2023
See Remarks
Sold, plan not stated
30,150
$348.84K
30.8%
DYN Dyne Therapeutics, Inc.
12 Dec 2022
See Remarks
Sold, plan not stated
472
$5.13K
0.5%
DYN Dyne Therapeutics, Inc.
11 Mar 2022
See Remarks
Sold, plan not stated
481
$4.20K
0.8%
DYN Dyne Therapeutics, Inc.
21 Sep 2021
See Remarks
Sold, plan not stated
729
$11.74K
2.0%
DYN Dyne Therapeutics, Inc.
20 Sep 2021
See Remarks
Sold, plan not stated
545
$8.51K
1.5%
28 decisions on file.